Global POC Infectious Diseases Market 2015-2019

POC感染症診断の世界市場2015-2019

◆タイトル:Global POC Infectious Diseases Market 2015-2019
◆商品コード:IRTNTR5761
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年4月29日
◆ページ数:72
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥324,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥432,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、POC感染症診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、POC感染症診断の世界市場規模及び予測、市場シェア、感染症別分析、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

・エグゼクティブサマリー
・市場概観
・業界の構造分析
・POC感染症診断の世界市場:市場規模及び予測
・POC感染症診断の世界市場:感染症別分析
・POC感染症診断の世界市場:地域別分析
・市場シェア
・購買基準
・市場成長要因
・市場の課題
・市場動向
・競争状況
・主要企業(ベンダー)分析
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About POC infectious diseases
POC diagnosis for infectious diseases refers to diagnostic tests performed near the site of patient care. The testing site is usually a patient’s bedside, physician’s clinic, ICU, operating room, emergency room, or wherever medical care may be necessary. A healthcare professional or a nurse attending the patient will obtain the specimen, perform analysis, and record the result. The main purpose of POC testing is to decrease the time between diagnosis and treatment. This test is either antibody-based or microbial particle-based detection method, which includes ELISA, agglutination, optical immunoassays, or lateral flow immunochromatography. Advances in POC technology has facilitated in data storage and data sharing and communication with public health agencies. Performing this test for screening infectious diseases extends its applications to the community practice setting. For instance, processing accurate data on the prevalence of influenza in community could help curtail inappropriate use of antibacterial agents and improve the allocation of vaccines to areas of highest need.

Technavio’s analysts forecast the global POC infectious disease market to grow at a CAGR of 7.50% over the period 2014-2019.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global POC infectious disease market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of testing kits and devices used for the major POC infectious diseases in the market. Based on diseases, the market can be divided into 10: flu, tuberculosis, malaria, RSV, adenovirus, infectious mononucleosis, fecal occult blood, HIV, strep. B, others (HCV, HBV, giardia, syphilis, and pneumonia).
Technavio’s report, the Global POC Infectious Disease Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global POC infectious disease market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key regions]
• Americas
• APAC
• EMEA

[Key vendors]
• Alere
• Meridian Bioscience
• Orasure Technologies
• Trinity Biotech

[Other prominent vendors]
• Abbott
• Beckman Coulter/ Danaher
• Becton Dickinson
• Biomerieux
• Bio-Rad
• Cepheid
• Diamedix
• Diasorin
• Eiken Chemical
• Enzo Biochem
• Fujirebio/ Innogenetics
• Grifols/ Novartis Diagnostics
• Humor Diagnostica
• Hologic/ Gen-Probe
• Nanogen/ Elitech
• Ortho-Clinical Diagnostics/ Johnson & Johnson
• Qiagen
• Roche Diagnostics
• SeraCare
• Siemens Healthcare
• Thermo Fisher Scientific

[Market driver]
• Increase in prevalence of infectious diseases
• For a full, detailed list, view our report

[Market challenge]
• Lack of awareness about POC devices
• For a full, detailed list, view our report

[Market trend]
• Shift from physician-centered to patient-centered model
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

1 Executive Summary
2 List of Abbreviations
3 Scope of the Report
3.1 Market overview
3.2 Product offerings
4 Market Research Methodology
4.1 Market research process
4.2 Research methodology
5 Introduction
6 Overview
7 Hospital-acquired Infections
8 Homecare Testing
8.1 Overview
8.2 Types of homecare
9 Market Landscape
9.1 Market overview
9.2 Market size and forecast
9.3 Five forces analysis
10 Market Segmentation by Diseases
10.1.1 RSV
10.1.2 Flu
10.1.3 Adenovirus
10.1.4 Malaria
10.1.5 Strep B
10.1.6 Tuberculosis
10.1.7 Fecal occult blood
10.1.8 HIV
10.1.9 Infectious mononucleosis
11 Geographical Segmentation
11.1 POC infectious diseases market in Americas
11.1.1 Market size and forecast
11.2 POC infectious diseases market in EMEA
11.2.1 Market size and forecast
11.3 POC infectious diseases market in APAC
11.3.1 Market size and forecast
12 Buying Criteria
13 Market Growth Drivers
14 Drivers and their Impact
15 Market Challenges
16 Impact of Drivers and Challenges
17 Market Trends
18 Trends and their Impact
19 Vendor Landscape
19.1 Competitive scenario
19.1.1 Key news
19.1.2 Mergers and acquisitions
19.2 Market share analysis 2014
19.3 Other prominent vendors
20 Key Vendor Analysis
20.1 Alere
20.1.1 Key facts
20.1.2 Business overview
20.1.3 Business segmentation by revenue 2013
20.1.4 Business segmentation by revenue 2012 and 2013
20.1.5 Geographical segmentation by revenue 2013
20.1.6 Business strategy
20.1.7 Recent developments
20.1.8 SWOT analysis
20.2 Meridian
20.2.1 Key facts
20.2.2 Business overview
20.2.3 Business segmentation by revenue 2014
20.2.4 Business segmentation by revenue 2013 and 2014
20.2.5 Geographical segmentation by revenue 2014
20.2.6 Business strategy
20.2.7 Recent developments
20.2.8 SWOT analysis
20.3 OraSure
20.3.1 Key facts
20.3.2 Business overview
20.3.3 Product segmentation
20.3.4 Business segmentation by revenue 2014
20.3.5 Business segmentation by revenue 2013 and 2014
20.3.6 Geographical segmentation by revenue 2014
20.3.7 Business strategy
20.3.8 Recent developments
20.3.9 SWOT analysis
20.4 Trinity Biotech
20.4.1 Key facts
20.4.2 Business overview
20.4.3 Business segmentation by revenue 2013
20.4.4 Business segmentation by revenue 2012 and 2013
20.4.5 Geographical segmentation by revenue 2013
20.4.6 Business strategy
20.4.7 Recent developments
20.4.8 SWOT analysis
21 Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market research methodology
Exhibit 2: POC testing market segmentation
Exhibit 3: Categorization of infectious diseases
Exhibit 4: HAIs in US
Exhibit 5: Estimated treatment cost and mortality associated with HAIs
Exhibit 6: Segmentation of HAI
Exhibit 7: Global POC infectious diseases market 2014-2019 ($ million)
Exhibit 8: Segmentation of market by disease types 2014
Exhibit 9: Regional malaria deaths
Exhibit 10: Regional malaria cases
Exhibit 11: WHO regional tuberculosis statistics
Exhibit 12: Demographic statistics for HIV
Exhibit 13: POC infectious diseases market by geography 2014
Exhibit 14: POC infectious diseases market by geography 2019
Exhibit 15: Segmentation of global POC infectious diseases market by geography 2014-2019
Exhibit 16: POC infectious diseases market in Americas 2014-2019 ($ million)
Exhibit 17: POC infectious diseases market in EMEA 2014-2019 ($ million)
Exhibit 18: POC infectious diseases market in APAC 2014-2019 ($ million)
Exhibit 19: Global POC Infectious Diseases Market: business segmentation by revenue 2013
Exhibit 20: Global POC Infectious Diseases Market: business segmentation by revenue 2012 and 2013 ($ billion)
Exhibit 21: Global POC Infectious Diseases Market: geographical segmentation by revenue 2013
Exhibit 22: Meridian: business segmentation by revenue 2014
Exhibit 23: Meridian: business segmentation by revenue 2013 and 2014 ($ million)
Exhibit 24: Meridian: geographical segmentation by revenue 2014
Exhibit 25: OraSure: product segmentation
Exhibit 26: OraSure: business segmentation by revenue 2014
Exhibit 27: OraSure: business segmentation by revenue 2013 and 2014 ($ million)
Exhibit 28: OraSure: geographical segmentation by revenue 2014
Exhibit 29: Trinity Biotech: business segmentation by revenue 2013
Exhibit 30: Trinity Biotech: business segmentation by revenue 2012 and 2013 ($ million)
Exhibit 31: Trinity Biotech: geographical segmentation by revenue 2013



【掲載企業】

Alere, Meridian Bioscience, Orasure Technologies, Trinity Biotech, Abbott, Beckman Coulter/ Danaher, Becton Dickinson, Biomerieux, Bio-Rad, Cepheid, Diamedix, Diasorin, Eiken Chemical, Enzo Biochem, Fujirebio/ Innogenetics, Grifols/ Novartis Diagnostics, Humor Diagnostica, Hologic/ Gen-Probe, Nanogen/ Elitech, Ortho-Clinical Diagnostics/ Johnson & Johnson, Qiagen, Roche Diagnostics, SeraCare, Siemens Healthcare, Thermo Fisher Scientific

【資料のキーワード】

POC感染症検査、感染症検査キット、感染症検査機器、RSV検査、インフルエンザ検査、結核菌感染診断、アデノウイルス検査、HIV検査、伝染性単核症検査、診断機器

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[POC感染症診断の世界市場2015-2019]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆